|
THIS WEEK IN MEDICAL TRAVEL TODAY Greetings, July is shaping up to be a remarkable month for the medical travel industry. Cheers, SPOTLIGHT Sandeep Khemka
In this issue's SPOTLIGHT we speak with Sandeep Khemka, CEO of Makewell Medical Travel (http://www.make-well.com), an emerging global player in the medical tourism field. We spoke with Khemka about what inspired him to pursue medical travel and his company's approach to providing end-to-end facilitation to patients. Medical Travel Today (MTT): Tell us a bit about why and how you got involved in global healthcare? Sandeep Khemka (SK): The original idea came from a very personal experience when my brother needed a kidney transplant. My family was, of course, looking for the best hospital and provider to do the procedure. It wasn't easy. The information was out there, but there was a lot of searching and matching that needed to be done. So from this experience I recognized a need for a service that matched people with the right doctor or specialist and the right hospital for their specific need. MTT: Recognizing that you're a relatively young company, what services are you offering at this time? SK: Our major focus is oncology, but many of our patients are seeking care for orthopedics, dental care, cosmetic surgery, ophthalmology, and cardiac disease. We anticipate that within six months we'll have established relationships with providers and facilities for all types of care and treatment. But we are being selective so some may take longer than others. MTT: In terms of hospitals you refer to, are you working only in India? And where are most of your patients coming from? SK: Our patients are really from around the world—the United States, Nepal, Canada, the U.K., and the Gulf Countries, just to name a few. We do work with many of the facilities in India like Fortis, Apollo Group, Wockhardt, Shroff Eye Hospital, and Lakeshore Hospital. We also work with SingHealth, Raffles, Parkways, and National Healthcare Group (NHG) in Singapore. MTT: How does the experience of working with you typically go for the patient? What's the process? SK: Usually a patient contacts us with their need. We then request their complete medical information and reports. We send this information to five or more of the best-suited facilities and physicians for consideration, depending on the condition. MTT: And what about follow-up after the patient has returned home? SK: When it's appropriate, we set up post-treatment follow-ups with the patient and the care provider. We're also working on a system where we can maintain patient reports and the physician can review them online. That's still in development, but once it's done, it will make things even easier and thorough. MTT: From what you told us earlier about your own family's past medical needs, how do you feel you're doing in terms of satisfying the needs you experienced? SK: I think we're doing very well. Our focus is really on the patient and making sure we do right by them. When you're in need of major medical care, you are feeling pretty exposed and vulnerable. We really try to make them feel more secure and confident in the choices they are making and give them options so they don't feel forced into something. Even after they arrive here and meet with the surgeon or specialist, if for some reason they don't feel confident, they can cancel without any financial penalties. That's how committed we are. Lessons in Healthcare from Giorgio Armani
Last month, the IHT ran an interesting story about how some of Europe’s leading luxury goods companies are shifting manufacturing from Europe to Asia. In the case of Giorgio Armani, some of their product lines are made exclusively in Asia. On the face of it, this is a totally unremarkable story – yet another company/industry outsourcing to save costs. But there is more. Luxury goods are different from toasters and TVs. Brand cache for luxury goods is anchored, in large part, to where they are made. You expect an Armani shirt to be manufactured in Italy, not China, and a BMW manufactured in Germany, not Mexico. And the same is true about Americans and healthcare; they expect it to be delivered in America and that’s what they are paying for. Americans have accepted the reality of globalization in cars and computers, but not in healthcare… or at least not yet. In healthcare, attitudes are significantly less global, and that is largely an issue of perception. As John Hooks, deputy managing director at Giorgio Armani, put it, “There is no reason why you can’t make good things anywhere in the world, as long as you have the artisans and the attention to quality. At the end of the day, it’s about perception.” Ostensibly, Armani products are the same, regardless of where they are manufactured. Same designer, same materials, same quality control processes. The only thing that sets one product apart from the other is the “made in” label. But Dr. Gupta, the Indian born, Harvard trained specialist working in Hyderabad, is faced with the same challenge as Armani—convincing Americans that quality is not tied to geography. Hooks says that manufacturing in Asia not only lowers production costs but allows Armani to spend more on fabrics and elaborate techniques that can actually improve the quality and sophistication of the final product. A convenient rationalization maybe, but most medical tourists would agree this statement. Overseas medical centers deliver a better patient experience because they can afford to spend more money on care. Armani’s approach to globalization is paradoxical. To compete globally they have to decouple their brand identity from the thing that makes their brand valuable – the “made in Italy” label. The same applies to healthcare in the US. For the US to compete as a world leader in healthcare, it may need to rethink its “slavish obsession”, as Hooks puts it, with where medical services are delivered and focus more on how those services are delivered. Ruben Toral Ruben Toral is a recognized leader in medical tourism and healthcare globalization. Formerly Group Marketing Director for Bumrungrad International, Toral is widely recognized as one of the driving forces behind medical tourism and Bumrungrad’s position as the world’s premier medical tourism destination. Now owner and operator of a healthcare marketing company, Mednet Asia Ltd., Toral has extensive healthcare experience. Toral shares his perspectives on the growing industry with Medical Travel Today on a monthly basis. Flights begin from China to Taiwan, Opening Medical Travel On Friday, July 4, 2008, the first regular weekend flights between China and Taiwan took place in the latest breakthrough in bilateral relations between the two countries. According to published reports, the first batch of nonstop weekend flights from the mainland carried 662 tourists on package tours from five cities. It's estimated the number of tourists could rise to as many as 3,000 per day. On the same day, several nonstop flights also carried passengers from Taiwan to the mainland. The flights are significant because this is the first time that "ordinary" Chinese citizens were allowed to visit Taiwan as tourists, a reform that potentially opens doors to medical travel between the two countries. According to Josef Woodman, author of the successful Patients Beyond Borders book series, "It's been long anticipated that flights to Taiwan from mainland China would open up great opportunities for medical travelers from the mainland who have little access to high-quality healthcare in China. This is very exciting news for Taiwan, and for China." Woodman's newest title, Patients Beyond Borders: Taiwan Edition will publish in English later this month and will be formally launched at the Medical Tourism North Asia Conference in Taipei, Taiwan on July 29. Reporting Quality of Care Abroad Because reporting on quality of care is of interest and importance to us all, we thought it might be interesting to see how hospitals abroad are approaching the issue. HCA Hospitals, the leading private healthcare provider in London, developed an online report covering such major areas of concern as infection rates, outcomes, Methicillin-resistant Staphylococcus aureus (MRSA), and cardiac survival. Available to consumers and professionals alike, the report is a comprehensive overview of the HCA's quality metrics and is updated annually based on data gathered at the individual hospital level. To view HCA's report, visit: www.hcaqualityreport.co.uk/introduction.asp Healthy Travel Media Launches Second Edition of Patients Beyond Borders
This impartial, easy-to-navigate trade paperback now gives health travelers more than 400 pages of the medical travel destinations, resources, and advice they need to make safe, cost-effective decisions about traveling abroad for their healthcare. "We're pleased to have added several new destinations to the Second Edition, including Israel, Jordan, Korea, New Zealand, Panama, the Philippines, Taiwan, and Turkey" says Josef Woodman, author of Patients Beyond Borders. "U.S. healthcare costs will rise yet another 6 percent in 2008, and another half million are expected to hit the ranks of the uninsured. Patients Beyond Borders has helped thousands travel abroad successfully for medical care, and the Second Edition now offers patients even greater choice" As the number of uninsured and underinsured Americans continues to grow, travel abroad for treatment is rising dramatically, with international hospitals and clinics reporting 15 to 40 percent increases in the number of Americans seeking treatment. More than 180,000 Americans will cross borders for healthcare this year; and that number is expected to nearly double by 2010. International patients looking to travel to specific destinations will now have five country-specific editions to choose from. With the upcoming releases of Patients Beyond Borders Taiwan (August 2008), Patients Beyond Borders India (September 2008), Patients Beyond Borders Singapore Second Edition (November 2008), Patients Beyond Borders Korea (November 2008), and Patients Beyond Borders Malaysia (Spring 2009), patients will have access to in-depth information on accredited hospitals, clinics, and specialty centers in a preferred destination. About Healthy Travel Media For more information, please visit: www.patientsbeyondborders.com. NBGH Offers Employers Tips to Evaluate Whether to Provide Medical Tourism Coverage WASHINGTON, DC, Jul 15, 2008 (MARKET WIRE via COMTEX) -- With the view that medical tourism may be an innovative approach to expanding access to lower cost, sometimes higher quality health care, the National Business Group on Health, a non-profit association of more than 300 large U.S. employers, today released an Issue Brief on Medical Tourism to inform and guide employers in their evaluation of this option for their organizations. The NBGH's Issue Brief on Medical Tourism comes at a time when a growing number of U.S. employers, consumers, and other stakeholders are investigating the benefits of going abroad for non-urgent medical procedures. Estimated at $60 billion in 2006, the size of the worldwide medical tourism market is projected to reach $100 billion by 2012. "As U.S. employers continue to explore cost-effective health care options for their organizations, medical tourism will continue to garner considerable attention and investment," said Helen Darling, President of the National Business Group on Health. "While robust media attention and key stakeholders continue to tout the significant cost differentials afforded by offshore care, and drive interest in this innovative approach, employers should have a clear understanding of the critical issues involved in medical tourism." The Issue Brief defines medical tourism and provides statistics about the current marketplace; identifies those procedures most commonly performed abroad; lists most frequented destination countries and evaluation of destination country standards, and explores the key drivers of current interest in/use of medical tourism. The Issue Brief also examines the critical issues necessary to effectively evaluate inclusion of medical tourism coverage, which include: quality of care, patient suitability, benefit coverage components, care coordination, legal/liability issues, and the potential versus actual cost savings of medical tourism. An employer case study and the results of a 2008 medical tourism survey of Business Group members are also included. "There are a number of significant reasons -- expanded access, cost-effectiveness, competitive pressures on U.S. providers, and safe health outcomes -- for employers to consider adding coverage of medical tourism to their benefits package," said Ms. Darling. "However, prior to facilitating treatment abroad, it's essential that employers undertake a comprehensive due diligence process to ensure that inclusion of this benefit is worthwhile for their organizations." About the National Business Group on Health The National Business Group on Health is the nation's only non-profit, membership organization of large employers devoted exclusively to finding innovative and forward-thinking solutions to their most important health care and related benefits issues. The NBGH identifies and shares best practices in health benefits, disability, health and productivity, related paid time off and work/life balance issues. NBGH members provide health coverage for more than 50 million U.S. workers, retirees and their families. For more information about the NBGH, visit www.businessgrouphealth.org. DESTINATION We're currently working on a new DESTINATIONS feature. To access archived DESTINATIONS, simply click on the links below: MEDICAL SPOTLIGHT: Stem Cell Therapies Stem cell therapies have been a topic of hot debate in the United States for some time. With the emergence of adult stem cell therapies, much of the ethical debate is dying down, and the focus is turning to the efficacy of the therapies. In the United States, where the therapies offered are limited and approval of procedures could take years, individuals with debilitating conditions are beginning to look abroad for hope. Dozens of organizations worldwide currently promote the use of stem cell therapies for treating conditions ranging from diabetes, cerebral palsy, brain injuries, and multiple sclerosis to rheumatoid arthritis, macular degeneration, autism, and heart disease. Experts and physicians are uneasy about the cures promised abroad as many of the host countries lack the rigorous clinical standards that exist here in the United States. Earlier this year, the International Society for Stem Cell Research (ISSCR), a task force of leaders in the field, announced a draft set of guidelines to ensure that rigorous best practices are applied to the clinical translation of stem cell research from the laboratory to human subjects. (When completed, the guidelines will be available at the ISSCR website.) According to Dr. George Q. Daley, ISSCR president and associate director of the Stem Cell Program at Children’s Hospital Boston, “These guidelines are critically important to the future success of the field. Not only does the use of untested therapies put patients at risk, it jeopardizes the legitimate practice of all translational stem cell research.” But with or without the guidelines, people worldwide continue to look for hope in the therapies. While the exact number of those seeking stem cell therapies is unknown, Saroja Mohanasundaram, CEO of Healthbase in India, says “We have received several queries from customers interested in stem cell treatment of ischemic heart disease, as in severe heart failure, which may not be treatable using conventional medications or surgery. Given that it is a safe procedure with low risk and that overseas hospitals offer a high cost advantage, we expect considerable interest in stem cell therapy among medical tourists.” The cost for treatments can range from $7,000 to $80,000, depending upon the destination, the nature of the treatment, and the number of rounds of treatment required. In March, National Public Radio reported 600 medical tourists have already traveled to China for stem cell treatments for $20,000 each. BridgeHealth International regularly sends patients to Costa Rica and Mexico for a variety of treatments. According to company president, Terry White, “Stem Cell therapy is an exciting opportunity for many patients to find significant improvement in a number of conditions. At BridgeHealth, we are focusing considerable time and attention on identifying high quality stem cell therapies for people around the world. We have sent a number of clients to a few locations and many have had great results. As a result, we are on the verge of a major announcement of a formal relationship with a major stem cell company that is devoted to providing the "gold standard" in stem cell therapies. They are committed to the advancement of the science and improving outcomes through tightly controlled outcomes measurements and improving protocols.” White adds, “Unlike many forms of medical travel that are about cost or quality, travel for stem cell treatment is most often about availability. Foreign providers are not competing with U.S. centers based upon price. “We see high levels of interest in autism, neurological conditions like strokes, traumatic brain injury, multiple sclerosis, spinal cord injuries, and diabetes. Great results are being obtained with orthopedics and tissue regeneration as well as ophthalmological conditions like macular degeneration.” White also notes that cost is a factor. “Most insurance companies do not cover these treatments,” says White, “so the financial considerations are particularly important for the individual. Through the BridgeHealth World-Class Provider Network, we provide access to the ‘gold standard’ in treatment centers which, even if not covered by insurance, are set up to provide the maximum benefit to the client, including access to valuable information on the subject.” In addition to the significant cost savings, stem cell patients are reported to be pleased with their treatment outcomes. Regennex, a Broomfield, CO-based company specializing in bone and joint treatments, reports an 80 percent success rate. Beike Biotech, a Chinese biotechnology company founded in 2005, reports that 70 to 80 percent of the more than 3,000 patients they’ve treated state they are satisfied with their results. People thinking of traveling for stem cell treatments should speak with their doctors and conduct research before traveling. Although patients have seen improvements in their conditions, stem cell treatments are not an overnight cure. The following sites provide information on stem cell procedures overseas:
Your Health Expos Offer Consumers Nationwide Opportunities to Explore Medical Travel Opportunities: The Medical Travel RoadShow Debuts in Six U.S. Cities RICHMOND, Va.— July 2008 — U.S. residents will have their first look at the vast array of options for accessing high quality medical care at significantly lower costs when the Medical Travel Road Show makes its first stops in six cities hosting Your Health Expos www.themedicalroadshow.com :
“Medical Tourism is an important trend and top-of-mind for U.S. healthcare consumers,” states Skip Brickley, director of The Medical Travel RoadShow and Your Health Expos, citing a recent Deloitte study showing that nearly 40 percent said they would travel outside the country for medical treatment if the quality was comparable and the cost was cut in half. “Texas was a logical location to kick-off this year-long schedule of medical travel and consumer health expos based upon the high level of interest among Texans for traveling to nearby destinations in Central and South America as well as Asia, New Zealand, Israel and other countries for documented high-quality care at a fraction of U.S. costs.” Brickley explains that hospitals, providers, medical travel experts, spas, and wellness centers throughout the world will be on hand to offer education and guidance. “This is the first series of shows to showcase these types of participants, and we look forward to meeting residents from all the states on our consumer health tour,” says Brickley. “A key component will be providers who perform cosmetic and elective procedures, since these surgeries are generally not covered by health plans.” These tours are focused on helping consumers find affordable healthcare solutions, and traveling overseas for medical care is a safe and high-quality option for all U.S. consumers. Brickley says that Americans are ready to take advantage of the benefits of medical travel and anxious to learn more about the latest developments in health and wellness. Attendees will have the opportunity to take part in a wide range of health and wellness activities, including personal visits with medical travel facilitators and providers; free health screenings; meetings with on-site personal trainers; and opportunities to learn more about healthy eating. “These expos are designed to meet the needs of all age groups and will be particularly valuable for those who do not have sufficient health insurance,” says Brickley. ”There will be a wealth of resources on hand to help people discover their options for specialty care including orthopedic, cardiac, dental, bariatric, and cosmetic surgery. Today, Americans are also interested in opportunities to access care that is not available in the United States, such as stem cell transplantation, organ transplants, as well as lower cost in-vitro fertilization (IVF). People are amazed that these options now exist.” Expo visitors can also take advantage of health screenings, including blood pressure and cholesterol testing, disease management counseling, healthy nutrition, fitness, and exercise coaching. Giveaways and prize drawings will supplement the informational and educational experience. Steven Tucker, M.D., president of the International Medical Travel Association (www.imta.org) and a leading U.S. board-certified medical oncologist adds, “As the fast-growing sectors of global healthcare and medical travel begin to influence patient choices, there are often more questions than answers. Your Medical Travel & Health Expos are designed to address every aspect of this important topic and provide a venue for better understanding of healthcare and the growing number of medical care options around the world.” Registration for the expos will soon be active. For general questions or assistance with registration, please contact Willie Moreno at 804.266.7422 ext. 7408 or willie@transmarx.com. Admission to Your Medical Travel & Health Expo is $5.00 per person when pre-registering online at www.themedicalroadshow.com. About Your Medical Travel & Health Expo About IMTA Asia’s biggest landmark healthcare congress – Global Health Conference (GHC) 2009—Announces Its Agenda: How Should Future Models in Healthcare Delivery be Re-Tooled to Handle Disease Management? Disease management will directly impact the future models of care. But what shape and form these models will take is of question. Will we see more of specialized hospitals? If so, where will they be located? How will innovative ‘disruptive’ technologies help the future healthcare cities and hospitals cater to and deal directly with new disease management? The future of healthcare delivery lies mostly in disease-based intervention programs. The healthcare cities and hospitals of the future will greatly benefit from a clearer understanding of how to effectively integrate disease management into future facilities and core competencies to be built. Another contributing factor that will shape future care models is the growing number of highly valued patients globally – many of whom are crossing international borders in search of quality care and access. How should hospitals convert their centers of excellence to cater to this growing sector? How can they adequately build capacity and expertise to ensure they are able to meet new and growing demands? Leaders in global healthcare will be tackling these issues head-on at Asia’s biggest landmark healthcare congress, GHC 2009, which will feature two co-located events, “Healthcare Cities & Hospitals of the Future” and “Crossing International Borders” (February 23-26, 2009, Singapore). For more information on the event, please visit www.magenta-global.com.sg/healthcare or kindly contact:- World Medical Tourism & Global Health Congress World Medical Tourism & Global Health Congress will be holding “The World’s Largest Global Healthcare Conference & Networking Session” in September in San Francisco. For More Information on the Congress visit www.MedicalTourismCongress.com or email Info@MedicalTourismCongress.com |
|
||||||
Editor's Note: This newsletter is for informational purposes only and should not be construed as medical advice.